Study of Testosterone vs Placebo in Testicular Cancer Survivors
Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
The overall purpose of the study is to evaluate the effect of 12 months testosterone
replacement therapy in testicular cancer survivors with mild Leydig Cell Insufficiency in
order to reduce the risk of cardiovascular disease.
The primary study objective is to evaluate changes in insulin sensitivity. The secondary
study objective is to evaluate changes in the prevalence of metabolic syndrome, body
composition, systemic inflammation and symptoms of testosterone deficiency.